Dr Reddys Laboratories Ltd witnessed a -0.35% decrease in its share price, and it is currently trading at ₹1,337.10. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.